ABI
CAH icon

Adamant Biomedical Investments’s Cardinal Health CAH Stock Holding History

Adamant Biomedical Investments’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$6.46M Sell
80,000
-25,000
-24% -$1.97M 1.54% 21
2014
Q3 		$7.87M Buy
+105,000
New +$7.64M 1.96% 15

Other funds holding CAH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adamant Biomedical Investments's CAH Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Cardinal Health (CAH) stake by 24% in Q4 2014, selling an estimated $1.97M and leaving 80,000 shares worth $6.46M. The position accounts for 1.54% of the portfolio, ranked #21.

Adamant Biomedical Investments first reported a position in CAH in Q3 2014 and has held it in 2 quarters since. The position peaked at $7.87M in Q3 2014. 708 funds tracked by Wall St. Rank hold CAH as of Q4 2014.

  • Adamant Biomedical Investments held 80,000 shares of Cardinal Health worth $6.46M as of Q4 2014.
  • Adamant Biomedical Investments sold 25,000 Cardinal Health shares in Q4 2014, an estimated $1.97M.
  • Cardinal Health made up 1.54% of Adamant Biomedical Investments's portfolio in Q4 2014, its #21 holding.
  • Adamant Biomedical Investments first reported a position in Cardinal Health in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's Cardinal Health position peaked at $7.87M in Q3 2014.
  • 708 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.